PATENT CLAIM ANALYSIS

Application Number: 15897597
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["435", "183000"]

Abstract:
An embodiment is a method of mitigating or treating Gastroesophageal Reflux Disease (GERD) caused by a neurological disorder that includes administering an effective amount of a medicament that includes a supernatant resulting from culturing  Lactobacillus bulgaricus  B-30892 bacteria to a human to mitigate or treat GERD caused by a neurological disorder.

Claim (Index 7):
The method of  claim 1  wherein the medicament further comprises an effective amount of parts of, or entirely broken up, microorganisms and/or their spores that are capable of providing PepO.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 88.0
- Lexical Diversity: 1.38462
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14863517', '15378779', '15436218', '13886424', '15395419']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5743782419217508
- 35 USC 102 Novelty (BERT): 0.5244595089336472
- Combined Prediction Score: 0.5693863686229405
- Mean Citation Score: 216.617562
- Max Citation Score: 293.13998
- Similarity Product: 181.35332567172645

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test